- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Scientists make sunscreens safe by using nanoparticle screening
Researchers have successfully used microchips to demonstrate titanium dioxide, a chemical found in most sunscreens, not only is nontoxic but also offers protection against ultraviolet damage to skin cells. Scientists are using nanoparticle screening on personal care products and finding previously thought toxic chemicals may not be harmful. The paper has been published in Biomicrofluidics.
Because of their minuscule size, nanoparticles of material don't have the same physical, chemical, mechanical or optical properties as the same material would on a bigger scale. This means that something that might not be toxic on a bigger scale could be toxic on a smaller scale and vice versa.
Author Craig Priest said a nanomaterial included in a personal care product may remain on the body for many hours and be exposed to air, moisture, light, and heat along with sweat, oils, and wax from the skin. This could either enhance or diminish toxicity.
The authors chose to investigate UV radiation for its simplicity and for its potential for inclusion in a multiparameter study between nanoparticles and external stressors, such as sunlight.
Previous nanotoxicity screening methods were laborious and time-consuming. Microfluidic devices present an optimistic future for nanoparticle analysis, offering reduced cost, small sample volumes, controllability, and reproducibility.
"Nanoparticles are found in many products and vary greatly. The exact size, shape, material and surface properties determine whether a particle is safe or harmful, but the vast number of property combinations means that screening is extremely difficult," Priest said.
The scientists built upon previous research, which tested microfluidic screening processes for chemicals, such as potassium cyanide, cycloheximide and chemotherapy drugs. A major advantage of using microfluidic devices is their ability to carry out multiple tests using small sample volumes in a compact microchip format.
"Our results will help speed the development of microfluidic screening chips and, in time, may form the basis of standardized screening of new nanoparticles before they enter products or the environment," Priest said.
This research is expected to expedite toxicity testing of consumer personal products, as well as enhance safety and regulation on nanoparticles.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd